New osteoporosis drug copycat tested in healthy volunteers
NCT ID NCT07384104
First seen Feb 03, 2026 · Last updated May 13, 2026 · Updated 15 times
Summary
This early-stage study tests whether a new drug called SAL023 works the same as the approved drug Evenity for osteoporosis. It involves 118 healthy Chinese adults aged 18-45. The main goal is to compare how the body processes each drug and to check for side effects. This is not a cure but aims to provide a more affordable treatment option for managing osteoporosis.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOPOROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Second Hospital of Anhui Medical University Clinical Pharmacology Research Center
Hefei, Anhui, 230601, China
Conditions
Explore the condition pages connected to this study.